It’s exciting news! The CEO of one of your investments tells you that a buyer expressed serious interest in acquiring her company for $30M. Since the company has struggled to find huge growth, you are relieved and do a quick mental “back of the envelope” calculation and you figure you’ve bagged a 5x return in a couple of years. Not too bad for one of your first angel deals!
- Delta Development Team Equips Kenosha WI EMS Carry Blood to the Frontline
- NuvOx Announces Positive Results 1st Cohort Phase Ib Trial
- Tech Parks Arizona Economic Impact
- Delta Development Team Exceeds New Prehospital Blood Transfusion Standards
- Clinical Trial Confirms GammaTile Superior Tumor Control
- 2025 Brutal Biotech Investment Climate
- Delta Development Team – Introducing BloodCOMM Premium
- Special Operations Forces Blood Cooler from Delta Development
- UACI startup alumni Reglagene making impressive strides in brain cancer treatment
- Reglagene RGN6024 Cover Story August 2025 Molecular Cancer Therapeutics